Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
TerrAscend Corp ( (TSE:TSND) ) has shared an announcement.
TerrAscend Corp announced it will host a conference call to discuss its third-quarter 2025 financial results on November 6, 2025. The announcement is significant for stakeholders as it provides insights into the company’s financial performance and strategic positioning in the competitive cannabis industry.
The most recent analyst rating on (TSE:TSND) stock is a Hold with a C$1.00 price target. To see the full list of analyst forecasts on TerrAscend Corp stock, see the TSE:TSND Stock Forecast page.
Spark’s Take on TSE:TSND Stock
According to Spark, TipRanks’ AI Analyst, TSE:TSND is a Neutral.
The overall stock score is primarily impacted by weak financial performance and poor valuation metrics, reflecting ongoing operational and profitability challenges. Despite these issues, the stock shows strong technical momentum, which provides some positive outlook in the short term.
To see Spark’s full report on TSE:TSND stock, click here.
More about TerrAscend Corp
TerrAscend Corp is a leading North American cannabis company with operations in Pennsylvania, New Jersey, Maryland, Ohio, and California, as well as retail operations in Canada. The company operates dispensary retail locations and has scaled cultivation, processing, and manufacturing facilities. TerrAscend offers a wide range of cannabis products to both medical and legal adult-use markets and owns or licenses several brands including The Apothecarium, Cookies, Lemonnade, and others.
Average Trading Volume: 332,690
Technical Sentiment Signal: Hold
Current Market Cap: C$491.7M
See more data about TSND stock on TipRanks’ Stock Analysis page.